Cocrystal Pharma
COCP · NASDAQ
$0.9429−$0.0037 (−0.39%)TodayMarket closed ·
Prev close $0.9466
Who owns COCP
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 97.0% of COCP’s shares.
- OPKO Health, Inc.41.3%
- Rubin (Steven D)19.3%
- Hassan (Fred)15.2%
- Frost Gamma Investments Trust14.5%
- Next 6 largest institutions6.7%
- All other shareholders3.0%
| Holder | Shares | % of shares |
|---|---|---|
| OPKO Health, Inc. | 5.69M | 41.28% |
| Rubin (Steven D) | 2.66M | 19.29% |
| Hassan (Fred) | 2.10M | 15.23% |
| Frost Gamma Investments Trust | 1.99M | 14.46% |
| Vanguard Capital Management, LLC | 358.23K | 2.60% |
| Renaissance Technologies LLC | 179.63K | 1.30% |
| Two Sigma Investments, LP | 175.38K | 1.27% |
| Geode Capital Management, L.L.C. | 76.21K | 0.55% |
| BlackRock Institutional Trust Company, N.A. | 73.75K | 0.53% |
| Lee (Sam Ph.D.) | 66.36K | 0.48% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 187.27K | 1.36% |
| Vanguard Extended Market Index Fund | 170.96K | 1.24% |
| Fidelity Extended Market Index Fund | 49.81K | 0.36% |
| Fidelity Series Total Market Index Fund | 9.63K | 0.07% |
| Fidelity Total Market Index Fund | 8.53K | 0.06% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $80.41K (2 trades) of COCP on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| FROST PHILLIP MD ET AL | Buy | 10.00K | $9.82K |
| FROST PHILLIP MD ET AL | Buy | 75.00K | $70.59K |
| SAPIRSTEIN JAMES | Award | 235.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 175.25K
- Days to cover
- 3.23
- % of shares outstanding
- 1.27%
- Average daily volume
- 54.34K
- Change since last report
- −45.7%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.